1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclopentanecarbonitrile

Catalog No. :
ACFSOJ654
CAS No. :
1956321-55-3
Molecular Formula :
C20H21N5O2
Molecular Weight :
363.42

IUPAC Name:1-(4-(4-amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclopentane-1-carbonitrile

1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclopentanecarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1473.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclopentanecarbonitrile
IUPAC Name1-(4-(4-amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclopentane-1-carbonitrile
MDL No.MFCD27991525
Molecular FormulaC20H21N5O2
Molecular Weight363.42
SMILESN#CC1(C2=CC=C(N3CCC4=NC(OC)=NC(N)=C4C3=O)C=C2)CCCC1
InChI KeyNMHHAAFLTKKFIB-UHFFFAOYSA-N
Synonym1-(4-(4-AMINO-2-METHOXY-5-OXO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDIN-6(5H)-YL)PHENYL)CYCLOPENTANECARBONITRILE;Cyclopentanecarbonitrile, 1-[4-(4-amino-7,8-dihydro-2-methoxy-5-oxopyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl]-
CAS No.1956321-55-3

Synthetic Route by SureRoute

1. ACFSOJ654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSOJ654 route product structure diagram
    ACFSOJ6541956321-55-3
Inquiry

2. ACFSOJ654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFSOJ654 route product structure diagram
    ACFSOJ6541956321-55-3
Inquiry

Comments (0)